Since the publication of the first genome-wide association study for cancer in 2007,
thousands of common alleles that are associated with the risk of cancer have been …

Introduction Risk‐stratified cancer screening has the potential to improve resource allocation
and the balance of harms and benefits by targeting those most likely to benefit. Public …

Background Introduction of risk stratification within population-based cancer screening
programmes has the potential to optimise resource allocation by targeting screening …

Simple Summary Oral cancer is among the twenty most common cancers worldwide.
Finding and treating this cancer early improves survival rates. Screening the whole …

Background Kidney cancer has become known as a metabolic disease. However, there is
limited evidence linking metabolic syndrome (MetS) with kidney cancer risk. This study …

Earlier detection and screening for kidney cancer has been identified as a key research
priority, however the low prevalence of the disease in unselected populations limits the cost …

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the
leading cause of liver-related morbidity and mortality. Although the invasive liver biopsy …

The incidence of renal cell carcinoma (RCC) has risen worldwide over the past few
decades, and this has been associated with a stage shift. Survival outcomes of RCC depend …

This study delves into the potential therapeutic benefits of Fufang Sanling Granules for
kidney cancer, focusing on their active components and the underlying mechanisms of their …

In the last 30 years, there has been an increasing incidence of oral cancer worldwide.
Earlier detection of oral cancer has been shown to improve survival rates. However, given …